Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

660
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
660

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Development and validation of a novel scoring scale for colonic endocytoscopy staining quality.

Scientific reports·2026
Same author

Development of deep learning-based narrow-band imaging endocytoscopic classification for predicting colorectal lesions from a retrospective study.

Nature communications·2025
Same author

Comparison of the diagnostic performance of narrow-band imaging endocytoscopy and staining-based endocytoscopy for colorectal lesions.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

DGCLCMI: a deep graph collaboration learning method to predict circRNA-miRNA interactions.

BMC biology·2025
Same author

The Impact of Autonomy Reform on the Efficiency of Public Hospitals in China: A DEA-ITSA Combination Analysis.

Risk management and healthcare policy·2025
Same author

CPL-Diff: A Diffusion Model for De Novo Design of Functional Peptide Sequences with Fixed Length.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

相关实验视频

Updated: Jun 11, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

药物向相互作用预测与协作对比学习和自适应的自步抽样策略.

Zhen Tian1,2, Yue Yu1,2, Fengming Ni3

  • 1School of Computer and Artificial Intelligence, Zhengzhou University, Zhengzhou, 450001, Henan, China.

BMC biology
|September 28, 2024
PubMed
概括

这项研究介绍了CCL-ASPS,这是一种用于药物向相互作用 (DTI) 预测的新深度学习模型. 它通过使用多个生物网络和更智能的负样本选择来提高DTI预测的准确性.

关键词:
相反的学习学习.药物-标相互作用 药物-标相互作用自我调节的样本采集

更多相关视频

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

653
Integration of Animal Behavioral Assessment and Convolutional Neural Network to Study Wasabi-Alcohol Taste-Smell Interaction
06:19

Integration of Animal Behavioral Assessment and Convolutional Neural Network to Study Wasabi-Alcohol Taste-Smell Interaction

Published on: August 16, 2024

399

相关实验视频

Last Updated: Jun 11, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

653
Integration of Animal Behavioral Assessment and Convolutional Neural Network to Study Wasabi-Alcohol Taste-Smell Interaction
06:19

Integration of Animal Behavioral Assessment and Convolutional Neural Network to Study Wasabi-Alcohol Taste-Smell Interaction

Published on: August 16, 2024

399

科学领域:

  • 生物信息学是一种生物信息学.
  • 计算化学计算化学
  • 药物发现 药物发现 药物发现

背景情况:

  • 药物向相互作用 (DTI) 的预测对于在药物发现和重新定位过程中识别潜在的候选药物至关重要.
  • 现有的方法往往无法充分利用跨多个生物网络的互补关系,阻碍了一致的表示学习.
  • 负样本的选择对DTI预测中的对比学习的表现产生了重大影响.

研究的目的:

  • 提出一种新的深度学习模型,CCL-ASPS,用于增强药物向相互作用预测.
  • 整合协作对比学习 (CCL) 和自适应自律抽样 (ASPS) 以提高表示一致性和负样本选择.
  • 通过利用多网络信息和动态采样来解决以前的DTI预测方法的局限性.

主要方法:

  • 开发了CCL-ASPS,这是一个结合协作对比学习 (CCL) 和自适应自律采样 (ASPS) 的深度学习模型.
  • 通过利用多个生物网络来实现一致的表示,CCL可以学习药物和目标的融合嵌入式.
  • ASPS动态选择有信息的负样本对来优化对比学习.

主要成果:

  • 与已建立的数据集上的最先进方法相比,CCL-ASPS在药物向相互作用预测准确度方面取得了显著的改进.
  • 废弃实验验证了协作对比学习和自适应自律采样策略的有效性和贡献.
  • 该模型在预测性能方面取得了显著的改进,证实了其有效性.

结论:

  • 拟议的CCL-ASPS模型通过整合CCL和ASPS,有效地克服了先前DTI预测方法的局限性.
  • CCL-ASPS显著提高了DTI的预测性能,与现有技术相比,它提供了更强大的方法.
  • 案例研究和冷启动实验凸显了CCL-ASPS在预测新药向相互作用方面的能力,有助于未来的药物发现工作.